“visterra” Archives

in
Entry Author Date Location
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge 11/22/16 National
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
With $2M, Codagenix Becomes Accelerate LI’s First VC-Backed Grad 06/12/15 New York
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software 12/16/14 New York
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Smart-Bug Maker Synlogic Nabs $5M From Gates Foundation 10/07/14 Boston
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
Visterra Obtains $30,000,000 Series B Funding 10/02/14 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody 12/02/13 Boston
Visterra Obtains $8,100,000 Series A Financing 12/02/13 Boston
Gates Foundation Invests in Flu Drug Developer Visterra 11/09/12 Boston
Visterra Obtains $13,000,000 Series A Financing 11/09/12 Boston
Recorded Future, GreenBytes, Seahorse, & More Boston-Area Dealmakers 05/30/12 Boston
Visterra Receives $12,906,300 New Round 05/29/12 Boston
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra 04/19/11 Boston
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News 07/14/10 Boston
Visterra, Previously Parasol, Expands with $6M 07/12/10 Boston
Visterra Lands $6,000,000 Series A Financing 07/09/10 Boston
Page 1 of 1